ep top consensu ztss ep beat
view better revenu profit factor line
ad maintain above-consensu ep
tp move greater convict near term prospect
handili exceed us growth plan
notabl strength companion anim vs estimate driven new
product apoquel cytopoint simparica rebound us livestock
vs estimate partial reflect neg impact recent vfd
treatment protocol shift dynam lap rose
ahead view strength companion apoquel
simparica livestock improv nice strength
aquacultur broad strength across major speci group gross
margin rose impress bp albeit bp plan
focu area investor admin expens fell bp bp
plan help drive strong ebit margin expans bp ahead
estim await cash flow balanc sheet data
pre-cal view share run higher top anim pick share
rise latest impress revenu acceler ep upsid
notabl issu highli anticip initi ep came
ahead consensu
oper revenu guid
respect encompass estim importantli
guidanc impli continu oper margin improv bp
key compon outperform thesi enhanc clariti help
instil greater convict acceler earn growth come
quarter effici initi meaning materi thesi
remain leader anim health highli lever
rebound industri fundament earn growth acceler
consist revenu growth improv cost structur capit
deploy opportun supplement growth risk includ shift
fundament demand slower traction newer product
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader develop anim health
therapeut livestock companion anim diversifi
portfolio product line directli market countri
industri largest sale forc
price feb rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
blue sky scenario assum meaning profit
contribut oper effici initi greater
expect adopt futur recent launch product
substanti share gain well stronger anticip growth
anim health fundament
grey sky scenario assum lower expect
ramp profit weaker traction new product potenti
distribut manufactur disrupt fx macroeconom
headwind weak companion product anim
compani mention price
